Join the club for FREE to access the whole archive and other member benefits.

Investment venture launches $10M for Scottish life sciences firms

16-Feb-2021

Key points from article :

Eos Advisory in strategic partnership with Kineticos to co-invest in early-stage Scottish life sciences companies.

Aim to invest more than £10m over five years in oncology-focused firms.

Medical needs in oncology, neurosciences and rare diseases, approaches to gene & cell therapies, and precision medicine.

Kineticos has a biotech advisory practice and a fund to invest in the advancement and commercialisation of clinical research.

Eos will engage with Scottish Enterprise and other private and public investors to support its co-investments.

"...help find and fund breakthrough ideas from Scotland's brightest life science entrepreneurs," - Kevin Grainger, founder of Eos.

"...will have a significant impact on improving the early diagnosis and treatment of cancer globally."

Eos Advisory and Kineticos collab will help find treatment for incurable cancers

Mentioned in this article:

Company

Investment firm based in Scotland

Company Representative

Chairman and founder of Eos Advisory

Company

Life sciences strategy consulting firm based in United States